academic article

• High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults. 2017
• Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults..  Blood.  129:572-581. 2017
• High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL..  Leukemia.  :-. 2017
• Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia..  Blood.  129:177-187. 2017
• Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. 2016
• Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia..  Nature communications.  7:-. 2016
• Characterization of leukemias with ETV6-ABL1 fusion..  Haematologica.  101:1082-1093. 2016
• Mesoporous Silica Nanoparticle-Supported Lipid Bilayers (Protocells) for Active Targeting and Delivery to Individual Leukemia Cells..  ACS nano.  :-. 2016
• Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma..  Cancer.  122:1017-1028. 2016
• Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia..  Cancer cell.  29:186-200. 2016
• Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232..  Blood.  :-. 2015
• Signalling thresholds and negative B-cell selection in acute lymphoblastic leukaemia..  Nature.  521:357-361. 2015
• Evaluation of the In Vitro and In Vivo Efficacy of the JAK Inhibitor AZD1480 against JAK-Mutated Acute Lymphoblastic Leukemia..  Molecular cancer therapeutics.  14:364-374. 2015
• A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults. 2015
• Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia..  Nature communications.  6:-. 2015
• Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. 2014
• SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia..  Blood.  121:148-155. 2013
• Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project..  Blood.  121:485-488. 2013
• ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  30:751-757. 2012
• Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia..  Blood.  120:833-842. 2012
• Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML..  Blood.  120:1473-1484. 2012
• Delivery of ricin toxin a-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers..  Advanced healthcare materials.  1:348-353. 2012
• Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers..  ACS nano.  6:2174-2188. 2012
• Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study..  Blood.  119:1872-1881. 2012
• Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia..  Cancer cell.  22:153-166. 2012
• Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia..  Blood.  120:4197-4204. 2012
• Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study..  Blood.  119:3512-3522. 2012
• Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia..  Blood.  120:3510-3518. 2012
• Treatment-influenced associations of PML-RAR? mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia..  Blood.  120:2098-2108. 2012
• Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia..  Nature genetics.  43:237-241. 2011
• Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles..  ACS nano.  5:5729-5745. 2011
• Drug Repurposing from an Academic Perspective..  Drug discovery today. Therapeutic strategies.  8:61-69. 2011
• Drug Repurposing from an Academic Perspective..  Drug discovery today. Therapeutic strategies.  8:61-69. 2011
• GSI-I (Z-LLNle-CHO) inhibits ?-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia..  Leukemia.  25:1135-1146. 2011
• Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group..  Blood.  118:3080-3087. 2011
• The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers..  Nature materials.  10:389-397. 2011
• Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710..  Blood.  116:3751-3757. 2010
• Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia..  Blood.  115:1394-1405. 2010
• Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome..  Blood.  116:4874-4884. 2010
• Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia..  Blood.  115:5312-5321. 2010
• Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia..  The New England journal of medicine.  360:470-480. 2009
• Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia..  JAMA.  301:393-403. 2009
• Germline genomic variants associated with childhood acute lymphoblastic leukemia..  Nature genetics.  41:1001-1005. 2009
• JAK mutations in high-risk childhood acute lymphoblastic leukemia..  Proceedings of the National Academy of Sciences of the United States of America.  106:9414-9418. 2009
• Metnase mediates chromosome decatenation in acute leukemia cells..  Blood.  114:1852-1858. 2009
• Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia..  Nature genetics.  41:1243-1246. 2009
• Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129..  Pediatric blood & cancer.  53:1005-1010. 2009
• Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's Oncology Group Study [corrected]..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  26:4376-4384. 2008
• Gene expression overlap affects karyotype prediction in pediatric acute lymphoblastic leukemia..  Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K.  21:1341-1344. 2007
• A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis..  Nature medicine.  12:945-949. 2006
• Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction..  Blood.  108:685-696. 2006
• Resolution of ambiguous low-level positive quantitative polymerase chain reaction results in TEL-AML1 positive ALL using a post-PCR fluorescent oligoligation method..  British journal of haematology.  135:358-361. 2006